Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 100, pseudogene (RNU6-100P)
- Target
- RNU6-100P
- Molecular classification
- Other (Pseudogene), Small nuclear RNA (snRNA)-derived pseudogene
01
Overview
RNA, U6 small nuclear 100, pseudogene (RNU6-100P) is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene. U6 snRNA plays a central role in the spliceosome complex that catalyzes pre-mRNA splicing, but RNU6-100P itself is a non-functional, non-coding pseudogene formed via retrotransposition mechanisms, primarily mediated by LINE-1 (L1) elements[7][1]. It does not produce functional RNA or protein, nor does it act as a traditional molecular target for therapeutic agents. Like other snRNA pseudogenes, RNU6-100P is an inactive genomic sequence and may serve as a marker of retrotranspositional events rather than playing an active regulatory or structural biological role[7][6][2].
- Other names
- RNU6-100PU6 snRNA pseudogene 100RNA, U6 small nuclear 100, pseudogene
02
Mechanism of action
None
03
Biological functions
None (no known biological function as a pseudogene); the parental gene (U6 snRNA) is involved in pre-mRNA splicing, but pseudogene copies are inactive
04
Disease associations
None (no direct known role in disease); may be markers of retrotransposition activity in genome studies
05
Biomarkers
None specific to RNU6-100P; U6 snRNA pseudogene patterns can be used in research as readouts of retrotransposition activity
Beyond the preview
Go deeper on RNA, U6 small nuclear 100, pseudogene (RNU6-100P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 100, pseudogene (RNU6-100P).